Machine learning helps predict which patients respond to immunotherapy
The DeepTCR system has shown its effectiveness as a predictive clinical tool and has provided insights into the biological mechanisms underlying patient response to immunotherapy. A machine learning algorithm predicted which melanoma patients would respond better to immunotherapy and which would not, according to a study by researchers at Johns Hopkins Kimmel Cancer Center and …
Machine learning helps predict which patients respond to immunotherapy Read More »